The treatment of nontoxic goitre with thyroxine and beta-blockers
Karaiskos, K.S.; Boukis, M.A.; Piperingos, G.D.; Kitsopanides, J.; Souvatzoglou, A.; Koutras, D.A.
Acta Endocrinologica. Supplementum 265: 41-42
1984
ISSN/ISBN: 0300-9750 PMID: 6593985 Document Number: 232057
Document emailed within 1 workday
Related Documents
Cizmáriková, R.; Valentová, J.; Hutt, A.J.; Sedláková, S. 2005: Blockers of beta-adrenergic receptors--a group of chiral agents stereoselective synthesis of beta-blockers Ceska a Slovenska Farmacie: Casopis Ceske Farmaceuticke Spolecnosti a Slovenske Farmaceuticke Spolecnosti 54(5): 201-206Kuo, S.W.; Hu, C.A.; Pei, D.; Ni, K.B.; Shian, L.R. 1993: Efficacy of thyroxine-suppressive therapy and its relation to serum thyroglobulin levels in solitary nontoxic thyroid nodules Journal of the Formosan Medical Association 92(1): 55-60
Lewinski, A. 2002: The problem of goitre with particular consideration of goitre resulting from iodine deficiency (II): management of non-toxic nodular goitre and of thyroid nodules Neuro Endocrinology Letters 23(4): 356-364
Held, P.H.; Yusuf, S. 1993: Effects of beta-blockers and calcium channel blockers in acute myocardial infarction European Heart Journal 14(Suppl): 18-25
Chourashy, B.K. 1988: Anti-anginal drugs: calcium channel blockers, beta-adrenergic blockers and nitrates Journal of the Indian Medical Association 86(10): 274-276
Coutts, L.C. 1997: Alpha blockers, diuretics and beta blockers for hypertension American Family Physician 55(7): 2431
Nakamura, T.; Hosohata, Y.; Hosohata, K.; Hattori, K.; Suzuki, J.; Nagatomo, T. 1999: Relationship between hydrophobicity and beta-blocking potencies, affinities or dissociation of beta-blockers from beta-adrenoceptors Research Communications in Molecular Pathology and Pharmacology 106(3): 203-211
Spinar, J.; Vítovec, J. 1998: Beta blockers in the treatment of arterial hypertension Casopis Lekaru Ceskych 137(9): 278-281
Johnson, S.; Newton, W. 1999: Beta-blockers for the treatment of congestive heart failure Journal of Family Practice 48(4): 247-248
Spinarová, L.; Spinar, J. 1998: Beta blockers in the treatment of chronic cardiac failure Vnitrni Lekarstvi 44(9): 558-562
Potocký, M.; Vodrázková, E. 1996: Beta-blockers in the treatment of open-angle glaucoma Ceska a Slovenska Oftalmologie: Casopis Ceske Oftalmologicke Spolecnosti a Slovenske Oftalmologicke Spolecnosti 52(6): 399-402
Goldfarb, D.; Iaina, A.; Eliahou, H.E. 1979: Treatment of hypertension solely with beta adrenergic blockers--why not? Harefuah 96(12): 681-683
Lefflerová, K.; Widimský, J.; Lupínek, Z. 1991: Beta-blockers in the treatment of hypertension in elderly patients Vnitrni Lekarstvi 37(2): 128-134
Celikić, S. 1991: Use of beta-blockers in the treatment of acute myocardial infarct Vojnosanitetski Pregled 48(5): 440-443
Carlier, J. 1979: The role of beta-blockers in the treatment of coronary diseases Revue Medicale de Liege 34(Suppl 1): 44-49
Nozawa, T.; Inoue, H. 1998: Treatment with beta-blockers in patients with acute coronary syndrome Nihon Rinsho. Japanese Journal of Clinical Medicine 56(10): 2612-2616
Sawicki, P.T.; Berger, M. 1992: Effects of antihypertensive treatment with beta-blockers on glucose metabolism Journal of Cardiovascular Pharmacology 20(Suppl 11): S45
Bonet, S.; Agustí, A. 1998: Efficacy of oral adrenergic beta blockers in the treatment of glaucoma Medicina Clinica 111(11): 419
Weser, C. 1982: Treatment of angina pectoris with special reference to beta-blockers Zeitschrift für Arztliche Fortbildung 76(6): 239-243
Horký, K. 1996: Do beta-blockers have a role in the modern treatment of arterial hypertension? Vnitrni Lekarstvi 42(6): 420-425